Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Regulus Therapeutics

Regulus Therapeutics reported $-7139000 in Pre-Tax Profit for its fiscal quarter ending in March of 2023.

Pre Tax Profit Change
Alnylam Pharmaceuticals ALNY:US USD -172362000 34.66M
AstraZeneca AZN:LN USD 3.71B 1.41B
Celldex Therapeutics CLDX:US USD -29361000 2.87M
Immunic Inc. VTL:US USD -25272000 31.2M
Intercept Pharmaceuticals ICPT:US USD -31881000 14.34M
Intrexon XON:US USD -22789000 621K
Ionis Pharmaceuticals IONS:US USD -113000000 81M
Merck & Co MRK:US USD 4.48B 411M
Regulus Therapeutics RGLS:US USD -7139000 344K
Sangamo BioSciences SGMO:US USD 21.33M 73.04M
Takeda 4502:JP JPY 47.92B 59.24B